CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $358,000 | -72.9% | 69,890 | -62.1% | 0.00% | -100.0% |
| Q2 2019 | $1,322,000 | -45.6% | 184,537 | +0.7% | 0.00% | -50.0% |
| Q1 2019 | $2,432,000 | +57.1% | 183,167 | -6.9% | 0.00% | 0.0% |
| Q4 2018 | $1,548,000 | -33.5% | 196,672 | -6.3% | 0.00% | 0.0% |
| Q3 2018 | $2,327,000 | -9.1% | 209,983 | +10.1% | 0.00% | 0.0% |
| Q2 2018 | $2,560,000 | +55.2% | 190,745 | +50.2% | 0.00% | 0.0% |
| Q1 2018 | $1,649,000 | +50.6% | 126,958 | +6.7% | 0.00% | +100.0% |
| Q4 2017 | $1,095,000 | – | 119,009 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
| Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
| Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
| Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
| Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
| Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
| Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
| MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |